122 related articles for article (PubMed ID: 26851089)
41. Development of diagnostic SCAR markers for genomic DNA amplifications in breast carcinoma by DNA cloning of high-GC RAMP-PCR fragments.
Fu S; Cheng J; Wei C; Yang L; Xiao X; Zhang D; Stewart MD; Fu J
Oncotarget; 2017 Jul; 8(27):43866-43877. PubMed ID: 28410206
[TBL] [Abstract][Full Text] [Related]
42. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma?
Projetti F; Lacroix-Triki M; Serrano E; Vergez S; Barres BH; Meilleroux J; Delisle MB; Uro-Coste E
J Oral Pathol Med; 2015 Apr; 44(4):244-51. PubMed ID: 25040635
[TBL] [Abstract][Full Text] [Related]
43. Generation of monoclonal antibodies against MGA and comparison of their application in breast cancer detection by immunohistochemistry.
Duan C; Yang X; Zhang X; Feng J; Liu Z; Que H; Johnson H; Zhao Y; Fan Y; Lu Y; Zhang H; Huang Y; Xiu B; Feng X
Sci Rep; 2015 Aug; 5():13073. PubMed ID: 26272389
[TBL] [Abstract][Full Text] [Related]
44. Molecular monitoring of epithelial-to-mesenchymal transition in breast cancer cells by means of Raman spectroscopy.
Marro M; Nieva C; Sanz-Pamplona R; Sierra A
Biochim Biophys Acta; 2014 Sep; 1843(9):1785-95. PubMed ID: 24747691
[TBL] [Abstract][Full Text] [Related]
45. Use of a panel of novel genes for differentiating breast cancer from non-breast tissues.
O'Brien N; O'Donovan N; Foley D; Hill AD; McDermott E; O'Higgins N; Duffy MJ
Tumour Biol; 2007; 28(6):312-7. PubMed ID: 18253069
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of aromatic amino acids as potential biomarkers in breast cancer by Raman spectroscopy analysis.
Contorno S; Darienzo RE; Tannenbaum R
Sci Rep; 2021 Jan; 11(1):1698. PubMed ID: 33462309
[TBL] [Abstract][Full Text] [Related]
47. Mammaglobin immunostaining in the differential diagnosis between cutaneous apocrine carcinoma and cutaneous metastasis from breast carcinoma.
Fernandez-Flores A
Cesk Patol; 2009 Oct; 45(4):108-12. PubMed ID: 20301838
[TBL] [Abstract][Full Text] [Related]
48. Human mammaglobin: a superior marker for reverse-transcriptase PCR in detecting circulating tumor cells in breast cancer patients.
Li G; Zhang J; Jin K; He K; Wang H; Lu H; Teng L
Biomark Med; 2011 Apr; 5(2):249-60. PubMed ID: 21473729
[TBL] [Abstract][Full Text] [Related]
49. Combining mammaglobin and carcinoembryonic mRNA markers for early detection of micrometastases from breast cancers--a molecular study of 59 patients.
Ghaffari SR; Sabokbar T; Tahmasebi S; Dastan J; Shorakae S; Moradi A; Tirgari F; Mohagheghi MA; Mosavi-Jarrahi A
Asian Pac J Cancer Prev; 2006; 7(3):396-8. PubMed ID: 17059329
[TBL] [Abstract][Full Text] [Related]
50. Phase transitions in oleic acid and in human breast tissue as studied by Raman spectroscopy and Raman imaging.
Brozek-Pluska B; Jablonska-Gajewicz J; Kordek R; Abramczyk H
J Med Chem; 2011 May; 54(9):3386-92. PubMed ID: 21476494
[TBL] [Abstract][Full Text] [Related]
51. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
[TBL] [Abstract][Full Text] [Related]
52. FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
Buck A; Schirrmeister H; Kühn T; Shen C; Kalker T; Kotzerke J; Dankerl A; Glatting G; Reske S; Mattfeldt T
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1317-23. PubMed ID: 12271413
[TBL] [Abstract][Full Text] [Related]
53. Raman spectra exploring breast tissues: comparison of principal component analysis and support vector machine-recursive feature elimination.
Hu C; Wang J; Zheng C; Xu S; Zhang H; Liang Y; Bi L; Fan Z; Han B; Xu W
Med Phys; 2013 Jun; 40(6):063501. PubMed ID: 23718612
[TBL] [Abstract][Full Text] [Related]
54. Angiogenesis - a crucial step in breast cancer growth, progression and dissemination by Raman imaging.
Kopeć M; Abramczyk H
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Jun; 198():338-345. PubMed ID: 29486925
[TBL] [Abstract][Full Text] [Related]
55. Characterization of human breast epithelial cells by confocal Raman microspectroscopy.
Yu C; Gestl E; Eckert K; Allara D; Irudayaraj J
Cancer Detect Prev; 2006; 30(6):515-22. PubMed ID: 17113723
[TBL] [Abstract][Full Text] [Related]
56. MRI evaluation of breast cancer.
Garrido-Laguna I; Fernandez Hidalgo O; Garcia Foncillas J
N Engl J Med; 2007 Jul; 357(2):191; author reply 193. PubMed ID: 17625133
[No Abstract] [Full Text] [Related]
57. Oncologic photodynamic diagnosis and therapy: confocal Raman/fluorescence imaging of metal phthalocyanines in human breast cancer tissue in vitro.
Abramczyk H; Brozek-Pluska B; Surmacki J; Musial J; Kordek R
Analyst; 2014 Nov; 139(21):5547-59. PubMed ID: 25203552
[TBL] [Abstract][Full Text] [Related]
58. Markers of metastatic carcinoma of breast origin.
Gown AM; Fulton RS; Kandalaft PL
Histopathology; 2016 Jan; 68(1):86-95. PubMed ID: 26768031
[TBL] [Abstract][Full Text] [Related]
59. Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breast-conserving therapy.
Uematsu T; Kasami M; Yuen S
Breast Cancer; 2009; 16(2):97-104. PubMed ID: 18663562
[TBL] [Abstract][Full Text] [Related]
60. Current management of ductal carcinoma in situ.
Barth A; Brenner RJ; Giuliano AE
West J Med; 1995 Oct; 163(4):360-6. PubMed ID: 7483593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
